Sarcoid and erythema nodosum arthropathies

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 14, Issue 3, 2000, Pages 461-476

  Pettersson, Tom ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Angiotensin converting enzyme; Arthritis; Bone cysts; Erythema nodosum; Granulomatous inflammation; Lofgren's syndrome; Myositis, sarcoidosis

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CALCIUM; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ACUTE DISEASE; ANGIOTENSIN BLOOD LEVEL; ARTHRITIS; BONE CYST; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CHRONIC DISEASE; CONNECTIVE TISSUE DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE MARKER; ERYTHEMA NODOSUM; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNOPATHOLOGY; LIVER TOXICITY; MYALGIA; MYOSITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS;

EID: 0033802980     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2000.0088     Document Type: Article

References (49)

1. Sarcoidosis
2. ATS/ERS/WASOG statement on sarcoidosis
3. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization
4. Pulmonary sarcoidosis in the Nordic countries 1950-1982: Epidemiology and clinical picture
5. Primary pulmonary sarcoidosis. I. Early signs and symptoms. II. Clinical course and prognosis
6. Immunology of sarcoidosis
7. + T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3
8. Etiology of sarcoidosis
9. Mycobacteria and sarcoidosis
10. Human herpesvirus 8 variants in sarcoid tissues
11. Genetics of sarcoidosis
12. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis
13. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis
14. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finish sarcoidosis patients
15. Serum angiotensin-converting enzyme levels in sarcoid arthritis
16. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients
17. The joint disease in sarcoidosis
18. The arthritis of sarcoidosis
19. Acute sarcoid arthritis: Occurrence, seasonal onset, clinical features and outcome
20. Ultrasound findings in Lofgren's syndrome: Is ankle swelling caused by arthritis, tenosynovitis or periarthritis?
21. Lofgren's syndrome revisited: A study of 186 patients
22. Histologic findings in siblings with acute sarcoid arthritis. Association with the B8, DR 3 phenotype
23. Recurrent Lofgren's syndrome in three patients with sarcoidosis
24. Acute sarcoid arthritis: A favourable outcome? A retrospective survey of 49 patients with a review of the literature
25. Synovitis with non-specific histological changes in synovium in chronic sarcoidosis
26. Myopathy in sarcoidosis: Clinical and pathological study of four cases and review of the literature
27. Sarcoidosis of bone
28. Muscle involvement in sarcoidosis
29. Lofgren's syndrome
30. Biochemical markers in sarcoidosis
31. Biochemical changes in sarcoidosis
32. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis
33. Vitamin D, calcium, and sarcoidosis
34. Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis
35. Serum angiotensin converting enzyme in sarcoidosis: Sensitivity and specificity in diagnosis: Correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy
36. The specificity and sensitivity of serum angiotensin-converting enzyme in sarcoidosis and other diseases. Experiences in 12 centers in six different countries
37. Sarcoidosis: TNF-α release from alveolar macrophages and serum level of sIL-2R are prognostic markers
38. Sarcoidosis in autoimmune diseases
39. Coexisting Sjogren's syndrome and sarcoidosis in the lung
40. Sarcoidosis in systemic sclerosis: Report of 7 cases
41. Systemic lupus erythematosus: An occasional misdiagnosis
42. Treatment with corticosteroids
43. Outcome in sarcoidosis: The relationship of relapse to corticosteroid therapy
44. Steroid-sparing alternative treatments for sarcoidosis
45. Low-dose methotrexate: An effective corticosteroid sparing agent in the musculoskeletal manifestations of sarcoidosis
46. Prolonged use of methotrexate in sarcoidosis
47. Sarcoidosis in young children
48. Systemic necrotizing vasculitis associated with childhood sarcoidosis
49. Early onset sarcoidosis: Not a benign disease